Soleno Therapeutics (SLNO) Q1 2026 Earnings

25FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.97
-0.38
0.21
0.8

Details

Expected EPS
0.710769
Actual EPS
0.8
Surprise EPS
0.09
Surprise Percent
+12.55%

Description

Soleno Therapeutics (SLNO) has reported earnings of 0.8 per share for Q1 2026.

0 Comments

Share your thoughts